Sipai Health Technology Co (HKSE:00314) Debt-to-EBITDA : -0.26 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Sipai Health Technology Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sipai Health Technology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$31 Mil. Sipai Health Technology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$43 Mil. Sipai Health Technology Co's annualized EBITDA for the quarter that ended in Dec. 2023 was HK$-287 Mil. Sipai Health Technology Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.26.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Sipai Health Technology Co's Debt-to-EBITDA or its related term are showing as below:

HKSE:00314' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.36 Med: -0.05 Max: -0.02
Current: -0.36

During the past 3 years, the highest Debt-to-EBITDA Ratio of Sipai Health Technology Co was -0.02. The lowest was -0.36. And the median was -0.05.

HKSE:00314's Debt-to-EBITDA is ranked worse than
100% of 75 companies
in the Medical Distribution industry
Industry Median: 2 vs HKSE:00314: -0.36

Sipai Health Technology Co Debt-to-EBITDA Historical Data

The historical data trend for Sipai Health Technology Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sipai Health Technology Co Debt-to-EBITDA Chart

Sipai Health Technology Co Annual Data

Trend

Dec21

Dec22

Dec23

Debt-to-EBITDA

-0.02

-0.05

-0.36

Sipai Health Technology Co Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-EBITDA	N/A	-	-0.03	-0.59	-0.26

Competitive Comparison of Sipai Health Technology Co's Debt-to-EBITDA

For the Medical Distribution subindustry, Sipai Health Technology Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sipai Health Technology Co's Debt-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sipai Health Technology Co's Debt-to-EBITDA falls into.

Sipai Health Technology Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sipai Health Technology Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(30.864	+	43.028)	/	-206.953
	=	-0.36

Sipai Health Technology Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(30.864	+	43.028)	/	-287.106
	=	-0.26

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.

Sipai Health Technology Co (HKSE:00314) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Sipai Health Technology Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sipai Health Technology Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Sipai Health Technology Co (HKSE:00314) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (HKSE:00314) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

AX1:Germany

Address

No. 1888, Caoyang Road, 7/F, Building 3, Xingguangyao Plaza, Putuo District, Shanghai, CHN

Website

https://www.medbankshealthtech.com

Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.

Sipai Health Technology Co (HKSE:00314) Headlines

No Headlines